Holen Sie sich die Stockscreener-App
5.74
8.31%
-0.52
Schlusskurs vom Vortag:
$6.26
Offen:
$6.3
24-Stunden-Volumen:
104.84K
Relative Volume:
0.94
Marktkapitalisierung:
$69.48M
Einnahmen:
$57.70M
Nettoeinkommen (Verlust:
$11.98M
KGV:
-9.9896
EPS:
-0.5746
Netto-Cashflow:
$-12.24M
1W Leistung:
-1.37%
1M Leistung:
+1.95%
6M Leistung:
-52.21%
1J Leistung:
-53.26%
1-Tages-Spanne:
$5.67
$6.42
1-Wochen-Bereich:
$5.59
$6.47
52-Wochen-Spanne:
$5.06
$13.47
Lensar Inc Stock (LNSR) Company Profile
Firmenname
Lensar Inc
Sektor
Branche
Telefon
888-536-7271
Adresse
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
5.74 | 69.48M | 57.70M | 11.98M | -12.24M | -0.5746 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-01 | Hochstufung | Lake Street | Hold → Buy |
| 2026-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2021-02-24 | Eingeleitet | SVB Leerink | Outperform |
Lensar Inc Aktie (LNSR) Neueste Nachrichten
LENSAR StockWeekly review in a volatile small-cap medtech sector - AD HOC NEWS
LENSAR Inc (LNSR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LENSAR Inc (LNSR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LENSAR Inc (LNSR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LENSAR Inc (LNSR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LENSAR Inc (LNSR) Valuation: PE, PB & Fair Value Analysis - TradingKey
LENSAR Inc (LNSR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LENSAR Inc (LNSR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LENSAR Inc (LNSR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENSAR (LNSR) Consolidates Near Support as Traders Eye Resistance at $6.11Box Spread - newsline.com
Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback - Stocktwits
LENSAR Q1 earnings call highlights - MSN
(LNSR) Risk Channels and Responsive Allocation - Stock Traders Daily
LNSR Technical Analysis & ETF Price Forecast - Intellectia AI
LENSAR (LNSR) director Ellis granted 17,421 RSUs and reports holdings - Stock Titan
Lensar (LNSR) director receives 17,421 RSUs, reports 1.1M+ indirect shares - Stock Titan
LENSAR (LNSR) grants 13,066 RSUs to principal accounting officer - Stock Titan
LENSAR (LNSR) COO granted 34,843 RSUs in four-year vesting award - Stock Titan
LENSAR (LNSR) CEO receives 130,662 RSUs vesting over four years - Stock Titan
LENSAR (LNSR) director Aimee Weisner receives 17,421 RSUs as annual equity grant - Stock Titan
LENSAR (LNSR) director awarded 17,421 RSUs as annual stock compensation - Stock Titan
LENSAR (LNSR) director Gary Winer receives 17,421 RSU equity award - Stock Titan
LENSAR (LNSR) director receives 17,421 RSUs as annual equity award - Stock Titan
LENSAR, Inc. (LNSR) director receives 17,421 RSU equity grant - Stock Titan
LENSAR (LNSR) Interim CFO Michael A. Rossi files initial SEC Form 3 - Stock Titan
How The LENSAR (LNSR) Story Is Shifting After The Failed Deal And New $10 Target - Yahoo Finance
Lensar Inc. Earnings Call Balances Recovery And Risk - The Globe and Mail
LENSAR Inc stock (US52633C1071): Q1 recurring revenue rose 9% - AD HOC NEWS
Lensar (LNSR) Q1 2026 Earnings Transcript - AOL.com
Lensar (LNSR) Q4 2025 Earnings Transcript - AOL.com
Lensar Reports First Quarter Fiscal 2026 Results; Management Highlights Strategic ProgressRevenue Inflection Point - newsline.com
Lensar (LNSR) Releases Q1 2026 Earnings Transcript: Key Insights for InvestorsGuidance Accuracy Score - The Legal Advocate
LENSAR Appoints Interim CFO, Accelerates Governance Timeline - The Globe and Mail
(LNSR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
LENSARAppoints Michael A. Rossi As Interim CFO Effective May 29, 2026 - TradingView
[8-K] LENSAR, Inc. Reports Material Event - Stock Titan
LENSAR, Inc. Announces Appointment of Michael A. Rossi as Interim Chief Financial Officer, Effective May 29, 2026 - marketscreener.com
LENSAR Inc stock (US52633C1071): Q1 2026 update and valuation snapshot after volatile Nasdaq trading - AD HOC NEWS
LNSR Earnings Overview 2026-05-28Growth Acceleration Report - thelegaladvocate.com
LENSAR (LNSR) Stock Edges Lower Amid Modest Selling Pressure — Key Levels in FocusQuote Data - newsline.com
Lensar Stock Rallies Into Memorial Day Break — Why Tuesday’s Open Matters - Bez Kabli
LNSR Earnings Overview 2026-05-22Crowd Stock Picks - Newser
LENSAR Inc. (LNSR) Gains 1.2% as Shares Test Key Resistance ZoneVolume Rate Change - The Legal Advocate
LENSAR (LNSR) Up +3.57% — 3 Reasons the Rally Could Continue 2026-05-21Zero Gamma Level - Newser
LENSAR Inc stock (US52633C1071): FDA clearance for ALLY lowers capital requirements for eye surgeons - AD HOC NEWS
LENSAR (LNSR) Gains +1.38% — Support Holds at $5.59 2026-05-20Dark Pool Prints - Newser
Liquidity Mapping Around (LNSR) Price Events - Stock Traders Daily
What LENSAR (LNSR)'s +1.62% Jump Means for Investors 2026-05-18Community Pattern Alerts - Newser
LENSAR stock (US52633C1071): eye-surgery specialist back in focus after Alcon deal collapse - AD HOC NEWS
LENSAR Inc stock (US52634T1034): laser eye surgery specialist in focus after latest business updates - AD HOC NEWS
LENSAR signals 2027 as really, really good year as it rebuilds distributor orders after Alcon deal termination - MSN
Finanzdaten der Lensar Inc-Aktie (LNSR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):